• Search History (Register)
  • MeSH Browser
  • [Clear]
    • English

Welcome to the international HTA database


Showing [16524 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2011     NIHR Horizon Scanning Centre (NIHR HSC) Dasatinib (Sprycel) for prostate cancer – in combination with docetaxel
2011     National Institute for Health and Care Excellence (NICE) Aripiprazole for the treatment of schizophrenia in people aged 15 to 17 years. NICE technology appraisal guidance 213
2011     Medical Advisory Secretariat (MAS) Continuous glucose monitoring for patients with diabetes
2011     HAYES, Inc. Progesterone for the prevention of preterm birth
2011     NIHR Horizon Scanning Centre (NIHR HSC) EC145 for folate receptor positive ovarian cancer
2011     HAYES, Inc. Recombinant human bone morphogenetic protein for use in spinal fusion
2011     NIHR Horizon Scanning Centre (NIHR HSC) Erlotinib (Tarceva) in combination with sorafenib (Nexavar) for unresectable, advanced or metastatic hepatocellular carcinoma – first line
2011     Health Information and Quality Authority (HIQA) Health technology assessment of robot-assisted surgery in selected surgical procedures
2011     HAYES, Inc. Recombinant human bone morphogenetic protein for use in tibia repair
2011     NIHR Horizon Scanning Centre (NIHR HSC) Heat-activated liposome encapsulated doxorubicin (ThermoDox) for hepatocellular carcinoma – first line
2011     HAYES, Inc. Robotically assisted stereotactic radiosurgery for intracranial indications
2011     NIHR Horizon Scanning Centre (NIHR HSC) Ipilimumab (Yervoy) for prostate cancer – second line
2011     HAYES, Inc. Robotically assisted stereotactic radiosurgery for thoracic and abdominal indications
2011     NIHR Horizon Scanning Centre (NIHR HSC) Masitinib with gemcitabine for advanced or metastatic pancreatic cancer
2011     Institute of Health Economics (IHE) Fecal transplantation for the treatment of clostridium difficile-associated disease or ulcerative colitis
2011     HAYES, Inc. Robotically assisted stereotactic radiosurgery (SRS) for spinal and extracranial head and neck indications
2011     NIHR Horizon Scanning Centre (NIHR HSC) Paclitaxel (Paclical) for epithelial ovarian cancer, fallopian tube cancer or peritoneal cancer – second or third line
2011     Medical Services Advisory Committee (MSAC) Use of artificial disc replacement in patients with cervical degenerative disc disease
2011     Institute for Clinical Evaluative Sciences (ICES) Geographic access to primary care and hospital services for rural and northern communities: Report to the Ontario Ministry of Health and Long-Term Care.
2011     NIHR Horizon Scanning Centre (NIHR HSC) Dalcetrapib for the prevention of cardiovascular events
2011     Medical Services Advisory Committee (MSAC) Assessment of application for joint injections
2011     HAYES, Inc. HLA-B*27 testing for ankylosing spondylitis
2011     NIHR Horizon Scanning Centre (NIHR HSC) Edoxaban tosylate for prevention of stroke and systemic embolic events in non-valvular atrial fibrillation
2011     Medical Services Advisory Committee (MSAC) Review of interim funded service: Hyperbaric Oxygen Therapy (HBOT) for the treatment of chronic non-diabetic wounds and non-neurological soft tissue radiation injuries
2011     Institute for Clinical Evaluative Sciences (ICES) Economic evaluation of percutaneous coronary intervention in stable coronary artery disease: studies in utilities, costs and decision modelling
2011     HAYES, Inc. KIT and PDGFRA testing for diagnosis of gastrointestinal stromal tumors (GISTs)
2011     NIHR Horizon Scanning Centre (NIHR HSC) HHLivC (Human Heterologous Liver Cells) for urea cycle disorders
2011     HAYES, Inc. KIT and PDGFRA testing for prognosis of gastrointestinal stromal tumors (GISTs)
2011     NIHR Horizon Scanning Centre (NIHR HSC) ThromboLUX™ for determining platelet quality
2011     Agenzia nazionale per i servizi sanitari regionali (Agenas) HIFU for the treatment of prostate cancer
2011     Medical Services Advisory Committee (MSAC) Review of MBS Items for specific ophthalmology services under the MBS Quality Framework Stage 1
2011     HAYES, Inc. Leri-weill dyschondrosteosis
2011     NIHR Horizon Scanning Centre (NIHR HSC) Rituximab (MabThera) for anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis
2011     University of York Supporting women with postnatal depression through psychological therapies
2011     HAYES, Inc. Topoisomerase II alpha (TOP2A) testing to predict response to treatment of breast cancer
2011     NIHR Horizon Scanning Centre (NIHR HSC) Odanacatib for post-menopausal osteoporosis – first or second line
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Abiraterone acetate (ZytigaTM) as 2nd-line therapy for the treatment of metastatic castration-resident prostate cancer after docetaxel therapy
2011     University of York Evidence briefing on specialist nurses in acute hospital settings
2011     HAYES, Inc. Canaloplasty (iTrack 250A canaloplasty microcatheter; iScience Interventional Inc.) for primary open-angle glaucoma
2011     NIHR Horizon Scanning Centre (NIHR HSC) Tocilizumab (RoACTEMRA) for early rheumatoid arthritis not treated with methotrexate – first line
2011     University of York Evidence briefing on nurse endoscopy
2011     HAYES, Inc. CellSearch circulating tumor cell (CTC) kit (Veridex LLC) for monitoring metastatic breast cancer
2011     NIHR Horizon Scanning Centre (NIHR HSC) Dimethyl fumarate for relapsing-remitting multiple sclerosis
2011     University of York Evidence briefing on integrated care pathways in mental health settings
2011     HAYES, Inc. C-leg prosthesis (Otto Bock HealthCare LP)
2011     NIHR Horizon Scanning Centre (NIHR HSC) Lacosamide (Vimpat) for epilepsy – first and second line
2011     HAYES, Inc. CMI magnetocardiograph model 2409 (CardioMag Imaging Inc.) for diagnosis of acute chest pain
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Aerosol-generating procedures and risk of transmission of acute respiratory infections: a systematic review
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Everolimus for the treatment of unresectable or metastatic neuroendocrine tumours of pancreatic origin
2011     HAYES, Inc. Cooled radiofrequency denervation of the sacroiliac joint (pain management sInergy system, Baylis Medical Co. Inc.) for treatment of chronic low back pain
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Guidelines and recommendations for ADHD in children and adolescents
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Rituximab (Rituxan®/MabThera®) for the first- and second-line treatment of chronic lymphocytic leukaemia
2011     Agenzia nazionale per i servizi sanitari regionali (Agenas) Systematic review of the methodological instruments used in Health Technology Assessment
2011     HAYES, Inc. EsophyX system with srosaFuse fastener (EndoGastric Solutions) for endoluminal repair for gastroesophageal reflux disease (GERD)
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal pre-operative testing and assessment for adult patients undergoing elective surgical procedures: a review of the clinical evidence and guidelines
2011     Agenzia nazionale per i servizi sanitari regionali (Agenas) Systematic review of economic evaluation on the use of PET-CT for cancer staging
2011     HAYES, Inc. Exhaled breath condensate pH testing for asthma management
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Transcatheter aortic valve implantation for aortic stenosis: a review of the clinical effectiveness and guidelines
2011     HAYES, Inc. Ex-PRESS glaucoma filtration device (Alcon Inc.) for treatment of primary open-angle glaucoma
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Multidisciplinary treatment programs for patients with non-malignant pain: a review of the clinical evidence, cost-effectiveness, and guidelines
2011     HAYES, Inc. eXtreme lateral interbody fusion (XLIF; NuVasive Inc.) for treatment of chronic low back pain
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Nabilone for chronic pain management: a review of clinical effectiveness, safety, and guidelines
2011     HAYES, Inc. Implantable interStim neurostimulator (Medtronic Inc.) for sacral neuromodulation in treatment of fecal incontinence in adults
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Endovascular thermal ablation technologies for treatment of varicose veins: a review of clinical effectiveness, safety, cost-effectiveness, and guidelines
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Strengthening the evidence base for a learning health system - Inspirations from good practice for capacity building in health services research and public health research
2011     HAYES, Inc. Implantable interStim neurostimulator (Medtronic Inc.) for sacral neuromodulation in treatment of fecal incontinence in children
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Combination therapy for pulmonary arterial hypertension: a review of the clinical effectiveness
2011     Institute for Clinical and Economic Review (ICER) Management options for low back disorders
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Octaplas compared with fresh frozen plasma to reduce the risk of transmitting lipid-enveloped viruses: an economic analysis and budget impact analysis
2011     HAYES, Inc. Mobile cardiac outpatient telemetry (MCOT) (CardioNet ambulatory ECG monitor; CardioNet Inc.) for home monitoring of cardiac patients
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Celecoxib versus non-COX-2 selective non-steroidal anti-inflammatory drugs: a review of the clinical effectiveness, safety, and cost effectiveness
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Ipilimumab for pre-treated patients with advanced/metastatic melanoma
2011     HAYES, Inc. Office-based phototherapy for treatment of atopic dermatitis in adults
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Celecoxib versus non-selective non-steroidal anti-Inflammatory drugs and proton pump inhibitors: clinical effectiveness, safety, and cost-effectiveness
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Nilotinib (Tasigna) for the 1st-line treatment of Philadelphia chromosome positive chronic myeloid leukemia in the chronic phase
2011     HAYES, Inc. Office-based phototherapy for treatment of atopic dermatitis in children
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Eliglustat tartrate, miglustat, imiglucerase, velaglucerase or a combination of these for the treatment of Gaucher disease: a review of clinical effectiveness and safety
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Cabazitaxel (Jevtana) for the second-line therapy of patients with hormone-refractory metastatic prostate cancer
2011     HAYES, Inc. OptiVol fluid status monitoring system (Medtronic Inc.) for management of heart failure
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Triaging patients from the emergency department to other medical centres: a review of the clinical evidence and guidelines
2011     HAYES, Inc. Portal vein embolization for liver regeneration followed by staged hepatectomy for cholangiocarcinoma
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Annual Report 2010. English version
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Functional Electric Stimulation (FES) for children with cerebral palsy: clinical effectiveness
2011     HAYES, Inc. Provenge (Dendreon Corp.) vaccine for treatment of prostate cancer
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Blood glucose monitors and test strips: a review of the comparative clinical evidence and cost-effectiveness
2011     HAYES, Inc. Relieva balloon sinuplasty (Acclarent Inc.) for treatment of chronic sinusitis
2011     NIHR Horizon Scanning Centre (NIHR HSC) IRay™ for wet age related macular degeneration
2011     Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR) Criteria for appropriate use of FDG-PET in esophageal cancer
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Dasatinib (Sprycel) for the first-line therapy of patients with newly diagnosed chronic phase philadelphia chromosome positive chronic myeloid leukemia.
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Umbilical cord clamp removal: a review of the clinical benefits and harms
2011     HAYES, Inc. Sacroiliac joint fusion for treatment of adult low back pain
2011     Technology Assessment Unit of the McGill University Health Centre (MUHC) X-ray versus gamma irradiation of blood components for prevention of transfusion-associated graft versus host disease: a brief report
2011     Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR) Criteria for appropriate use of FDG-PET in colorectal cancer
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Non-stress testing for pregnant adults with diabetes
2011     HAYES, Inc. Sensei X robotic catheter system (Hansen Medical Inc.) for treatment of atrial fibrillation
2011     Technology Assessment Unit of the McGill University Health Centre (MUHC) The use of Lactobacillus probiotics in the prevention of antibiotic associated clostridium difficile diarrhea
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Surgical dressing for patients undergoing hip or knee arthroplasty: clinical effectiveness and cost-effectiveness
2011     HAYES, Inc. SNaP wound care system (Spiracur Inc.) for treatment of lower extremity ulcers
2011     Technology Assessment Unit of the McGill University Health Centre (MUHC) Drug eluting stents. What should be the indications for their use at the MUHC?
2011     National Institute for Health and Care Excellence (NICE) MiraQ for assessing graft flow during coronary artery bypass graft surgery. NICE medical technologies guidance 8